American Board of Surgery - Surgery
Education & Training
1992, Vanderbilt University
Medical / Professional School(s)
1997, Keck School of Medicine of the University of Southern California
1998, General Surgery - Massachusetts General Hospital
2004, General Surgery - Massachusetts General Hospital
2005, Laparoscopic Surgery - Carolinas Medical Center
2002, Minimally Invasive Surgery - Cleveland Clinic
Gastrointestinal Surgery, Gastrointestional Cancer, Hernia Surgery, Laparoscopic and Minimally Invasive Surgery, Upper Gastrointestinal Cancer
Endoscopic diagnosis of duodenal stenosis in a 5-month-old male infant.
Nicholson MR, Acra SA, Chung DH, Rosen MJ
Enhanced recovery after surgery pathway for abdominal wall reconstruction: pilot study and preliminary outcomes.
Fayezizadeh M, Petro CC, Rosen MJ, Novitsky YW
Developmental hearing loss impairs signal detection in noise: putative central mechanisms.
Gay JD, Voytenko SV, Galazyuk AV, Rosen MJ
The impact of developing a comprehensive hernia center on the referral patterns and complexity of hernia care.
Raigani S, De Silva GS, Criss CN, Novitsky YW, Rosen MJ
Electronic cigarettes. A position statement of the forum of international respiratory societies.
Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, Sansores R, Van Zyl-Smit R, Forum of International Respiratory Societies
Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.
Gao Y, Krpata DM, Criss CN, Liu L, Posielski N, Rosen MJ, Novitsky YW
Single-center experience with parastomal hernia repair using retromuscular mesh placement.
Raigani S, Criss CN, Petro CC, Prabhu AS, Novitsky YW, Rosen MJ
Functional abdominal wall reconstruction improves core physiology and quality-of-life.
Criss CN, Petro CC, Krpata DM, Seafler CM, Lai N, Fiutem J, Novitsky YW, Rosen MJ
Small intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitis.
Weitkamp JH, Rosen MJ, Zhao Z, Koyama T, Geem D, Denning TL, Rock MT, Moore DJ, Halpern MD, Matta P, Denning PW
Qiao R, Rosen MJ, Chen R, Wu S, Marciniuk DD, Wang C
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
For calendar year 2012, Michael Rosen, MD disclosed the following Outside Relationships with Industry:
Davol - Consulting
LifeCell - Consulting